Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.

Health Diagnostics

Health Care

Biotechnology

Exosome Diagnostics

Benjamin Sawicki

Chelsea S.

Hilary Graham Ph.D.

Dan Baughman

Matthew Dindinger

Johan Skog

Kelli Neary

Jason M Alter

Kaitlyn Xavier

Mark Cate

Lorinda Hedstrom

Hannah Soulard

Brian Raifsnider

Katelyn Silk

Kimberly Altschuler

Chris Bentis

Frances Perez

Krishna Champaneria

The Sales and Account Management team at Exosome Diagnostics is responsible for driving the adoption of the company's biofluid-based molecular diagnostic tests within the healthcare market. They engage with healthcare providers and laboratories, fostering relationships and delivering tailored solutions to meet client needs. By leveraging their expertise in personalized medicine, the team ensures that clients understand the benefits of using exosome technology for diagnosing diseases, ultimately contributing to improved patient outcomes.

Sales and Account Management

Research and Development

Engineering and Quality Assurance

��

Sales and Account Management

About

Team members

Other teams at Exosome Diagnostics

Research and Development

Engineering and Quality Assurance

��������

Sales and Account Management

About

Team members

Other teams at Exosome Diagnostics

Research and Development

Engineering and Quality Assurance

��